Ready-to-use AI-driven applications to discover and evaluate predicted novel targets to improve preclinical pipeline performance
Novel targets to drive the preclinical pipeline
We work closely with many pharmaceutical & biotech companies to accelerate and de-risk their Target discovery process. Euretos' computational, AI-driven disease models predict novel target associations that domain experts can evaluate rapidly using our AI-integrated knowledge base.
Ranked target predictions from AI-driven, computational disease models
Biomolecular, data-driven approach that maximises discovery potential
Your domain experts assess results using the Euretos AI Platform
We support purchasing via scientist.com and science exchange!
Maximise target discovery potential
To find truly novel targets, we focus on biomolecular and experimental data. By taking into account the diseases associated with a target’s biological interaction networks we find yet unexplored disease associations.
Empower your domain experts to evaluate target predictions
We provide our clients domain experts access to the Euretos AI Platform to evaluate the predicted targets. Here they can assess key target and disease aspects such as multi-omics interactions, gene expression in tissues, cell types and tumors, pathway interactions, regulatory and signalling responses, gene variants, clinical trials, target tractability and patents.
360 degree biological, functional and commercial target evaluation
As part of the Euretos AI platform, researchers will have access to the Target Evaluation workflow with relevant expression data (tissue, cell type, tumor, cell line), functional annotations, pathway analysis, drug candidates, patents, clinical trials and more! Much of this data is difficult to find or integrated manually by Euretos. This enables a rapid and comprehensive evaluation of a target within a specific disease or phenotypical context.
Enabling world leading pharma, biotech and academic institutions
As our computational disease models and AI-integrated knowledge base are ready-to-use, the onboarding process for new clients is very rapid. In-app tutorials and close support of our translational scientists accelerate the learning curve even further.